GOTHENBURG, SE / ACCESS Newswire / May 13, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 13, ...

Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, published on major advances to Enchant, Iambic’s ...

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

Factors Affecting the Growth of the Artificial Intelligence For Drug Development and Discovery Industry: ...

FDA Commissioner Marty Makary’s proposal to roll out a new drug approval pathway is heightening hope for the rare disease ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

An FDA-designated orphan drug that can target a key vulnerability in lung cancer shows promise in improving the efficacy of ...

A $1.25 million investment is driving the development of a new treatment for advanced and therapy-resistant prostate cancer ...

Elliott is a very successful and astute activist investor. The firm's team includes analysts from leading tech private eq ...